{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:33:12Z","timestamp":1783398792712,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.clml.2012.01.008","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T00:23:42Z","timestamp":1331943822000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?"],"prefix":"10.1016","volume":"12","author":[{"given":"Dron","family":"Gauchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"DeBari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunwant","family":"Guron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maroules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2012.01.008_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.01.008_bib2","first-page":"14","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leucemia"},{"key":"10.1016\/j.clml.2012.01.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2004.02.002","article-title":"Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders","volume":"19","author":"Kralovics","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.clml.2012.01.008_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0377-4929.77355","article-title":"JAK2-positive Philadelphia-negative myeloproliferative neoplasms","volume":"54","author":"Sharma","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.clml.2012.01.008_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/msj.20225","article-title":"Myeloproliferative neoplasms: new translational therapies","volume":"77","author":"Mascarenhas","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.clml.2012.01.008_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1096-8652(200010)65:2<136::AID-AJH8>3.0.CO;2-6","article-title":"High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders","volume":"65","author":"Faurschou","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2012.01.008_bib7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1373\/clinchem.2006.073882","article-title":"Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes","volume":"52","author":"Bowen","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.clml.2012.01.008_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.1999.01340.x","article-title":"Homocysteine levels in polycythaemia vera and essential thrombocythaemia","volume":"105","author":"Gisslinger","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.01.008_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood.V18.6.717.717","article-title":"The plasma disappearance of radioactive vitamin B12 in myeloproliferative diseases and other blood disorders","volume":"18","author":"Hall","year":"1961","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.01.008_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-71-4-719","article-title":"Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease","volume":"71","author":"Gilbert","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2012.01.008_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.clinbiochem.2003.08.004","article-title":"Significance of elevated cobalamin (vitamin B12) levels in blood","volume":"36","author":"Ermens","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clml.2012.01.008_bib12","first-page":"680","article-title":"Causes and early diagnosis of vitamin B12 deficiency","volume":"105","author":"Herrmann","year":"2008","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.clml.2012.01.008_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3945\/ajcn.111.013441","article-title":"Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications and performance characteristics of cobalamin, methylmalonic acid and holotranscobalamin II","volume":"94","author":"Carmel","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clml.2012.01.008_bib14","first-page":"2789","article-title":"Diagnosis of vitamin B12 deficiency revised","volume":"149","author":"Wiersinga","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.clml.2012.01.008_bib15","first-page":"861","article-title":"Diagnosis of vitamin B12 deficiency: only apparently child's play","volume":"129","author":"B\u00e4chli","year":"1999","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.clml.2012.01.008_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1373\/clinchem.2005.057810","article-title":"The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth","volume":"52","author":"Obeid","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.clml.2012.01.008_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.111.015222","article-title":"Monitoring of vitamin B12 nutritional statue in the United States by using plasma methlmalonic acid and serum vitamin B12","volume":"94","author":"Bailey","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clml.2012.01.008_bib18","first-page":"70","article-title":"Why vitamin B12 deficiency should be managed aggressively","volume":"44","author":"McRae","year":"1989","journal-title":"Geriatrics"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:22:18Z","timestamp":1761870138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265012000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S2152265012000092"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.01.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}